Coya Therapeutics Presents Biomarker Data on Neuroinflammatory Pathways in Frontotemporal Dementia at the ADPD 2024 Conference

COYA Stock   7.08  0.35  5.20%   
About 55% of Coya Therapeutics,'s investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Coya Therapeutics, Common suggests that some traders are interested. The current market sentiment, together with Coya Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Coya Therapeutics, Common stock news signals to limit their universe of possible portfolio assets.
  
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing biologics primarily focused on the restoration of

Read at businesswire.com
businesswire News
  

Coya Therapeutics, Fundamental Analysis

We analyze Coya Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coya Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coya Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Net Income

Net Income Comparative Analysis

Coya Therapeutics, is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Coya Therapeutics, Common Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics, stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics, could also be used in its relative valuation, which is a method of valuing Coya Therapeutics, by comparing valuation metrics with similar companies.

Peers

Coya Therapeutics, Related Equities

NAMSWNewAmsterdam Pharma   19.37   
0%
100.0%
GANXGain Therapeutics   12.11   
0%
62.0%
INABIn8bio   8.00   
0%
41.0%
TCRXTscan Therapeutics   3.96   
0%
20.0%
CNTACentessa Pharmaceuticals   3.25   
0%
16.0%
STROSutro Biopharma   2.58   
0%
13.0%
FENCFennec Pharmaceuticals   2.18   
0%
11.0%
ABOSAcumen Pharmaceuticals   1.59   
0%
8.0%
HLVXHillevax   0.56   
2.0%
0%
CUECue Biopharma   0.81   
4.0%
0%
INZYInozyme Pharma   0.83   
4.0%
0%
LTRNLantern Pharma   1.00   
5.0%
0%
DRMADermata Therapeutics   1.72   
8.0%
0%
TERNTerns Pharmaceuticals   1.86   
9.0%
0%
CGTXCognition Therapeutics   2.17   
11.0%
0%
OPTOpthea   2.61   
13.0%
0%
DAWNDay One   4.03   
20.0%
0%

Complementary Tools for Coya Stock analysis

When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like